

@article {549,
	title = {European guidelines for diagnosis and treatment of adenovirus infection in leukemia and stem cell transplantation: summary of ECIL-4 (2011)},
	journal = {Transpl Infect Dis},
	volume = {14},
	number = {6},
	year = {2012},
	note = {1399-3062 Matthes-Martin, S Feuchtinger, T Shaw, P J Engelhard, D Hirsch, H H Cordonnier, C Ljungman, P Fourth European Conference on Infections in Leukemia Journal Article Review Denmark Transpl Infect Dis. 2012 Dec;14(6):555-63. doi: 10.1111/tid.12022. Epub 2012 Nov 12.},
	pages = {555-63},
	type = {Journal Article},
	abstract = {Human adenovirus (HAdV) infections are increasingly recognized as important pathogens in immunocompromised hosts, especially in patients with severely suppressed T-cell function. The 4th European Conference of Infections in Leukemia (ECIL-4) has developed evidence-based guidelines for diagnosis and management of HAdV infections. The risk for HAdV-associated disease is increased in children, and risk factors for HAdV disease are T-cell depletion, unrelated and cord blood hematopoietic stem cell transplantation, graft-versus-host disease grades III-IV, and lymphopenia. The recommended technique for monitoring of high-risk patients is quantitative polymerase chain reaction. Cidofovir is the most used antiviral therapy, although no controlled study has been performed. HAdV-specific T-cell therapy is in development.},
	keywords = {Adenovirus Infections, Human/*diagnosis/etiology/*therapy Europe Humans Leukemia/*complications *Practice Guidelines as Topic Stem Cell Transplantation/*adverse effects},
	issn = {1398-2273},
	doi = {10.1111/tid.12022},
	author = {Matthes-Martin, S. and Feuchtinger, T. and Shaw, P. J. and Engelhard, D. and Hirsch, H. H. and Cordonnier, C. and Ljungman, P.}
}
